This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Open AccessSystematic Review
Existing Evidence from Economic Evaluations of Antimicrobial Resistance—A Systematic Literature Review
by
Sajan Gunarathna
Sajan Gunarathna
Sajan is affiliated with the Policy and Economic Research Department at the International Vaccine of [...]
Sajan is affiliated with the Policy and Economic Research Department at the International Vaccine Institute, Seoul, Republic of Korea. He actively contributes to the health economics components of multiple research projects and played a key role in a World Bank initiative to establish and manage Sri Lanka’s largest maternal cohort, the Rajarata Pregnancy Cohort. His research interests focus on health economics and public health, particularly the economic burden of diseases in underserved rural and remote communities. He has experience in examining the economic dimensions of maternal morbidities and Strep A disease, as well as engaging in policy advocacy related to antimicrobial resistance.
,
Yongha Hwang
Yongha Hwang
Yongha Hwang is currently affiliated with the International Vaccine Institute (IVI). He holds a in a [...]
Yongha Hwang is currently affiliated with the International Vaccine Institute (IVI). He holds a master’s degree in Applied Economics and a bachelor’s degree in Economics. His professional experience includes serving as a data analyst at the National Cancer Center and contributing to consulting projects on policy and customer strategy for government departments and public enterprises in South Korea. Since 2023, he has been working at IVI with a focus on vaccine-related policy and economic evaluation. His research interests include assessing the cost of illness associated with typhoid and conducting cost-effectiveness analyses of typhoid conjugate vaccine introduction.
and
Jung-Seok Lee
Jung-Seok Lee *
International Vaccine Institute, Seoul 08826, Republic of Korea
*
Author to whom correspondence should be addressed.
Antibiotics 2025, 14(11), 1072; https://doi.org/10.3390/antibiotics14111072 (registering DOI)
Submission received: 23 September 2025
/
Revised: 20 October 2025
/
Accepted: 22 October 2025
/
Published: 24 October 2025
Abstract
Background/Objectives: Although antimicrobial resistance (AMR) is recognized as a critical global health threat across human, animal, and environmental domains, evidence from AMR economic evaluations remains limited. This study systematically reviewed available studies, emphasizing existing evidence and reported limitations in AMR-related economic evaluations. Methods: A comprehensive review of peer-reviewed empirical studies was conducted, including publications up to July 2023 without temporal restrictions, but limited to English-language articles. Literature searches were undertaken in PubMed and Cochrane using a search strategy centered on the terms “economic evaluations” and “antimicrobial resistance.” Screening and data extraction were performed by two reviewers independently, with disagreements resolved through consensus or consultation with a third reviewer. Findings were synthesized narratively. Results: Of the 3682 records screened, 93 studies were included. Evidence gaps were identified across income and geographic regions, particularly in low- and middle-income countries (LMICs) and the African, Southeast Asian, and Eastern Mediterranean regions. Studies were comparatively more numerous in high-income countries (HICs) and the European and Americas regions. Substantial gaps also existed in one health approach and community-based evaluations. Nine major study limitations were identified, with many interlinked. The most frequent issues included limited generalizability primarily due to inadequate sampling approaches (n = 16), and single-center studies (n = 11), alongside errors in cost estimation (n = 4), and lack of consideration for essential features or information (n = 3). Conclusions: The review highlights persistent evidence gaps and recurring methodological shortcomings in AMR economic evaluations. Addressing these limitations, particularly in LMICs, will strengthen the evidence base and better inform policy implementation to combat AMR effectively.
Share and Cite
MDPI and ACS Style
Gunarathna, S.; Hwang, Y.; Lee, J.-S.
Existing Evidence from Economic Evaluations of Antimicrobial Resistance—A Systematic Literature Review. Antibiotics 2025, 14, 1072.
https://doi.org/10.3390/antibiotics14111072
AMA Style
Gunarathna S, Hwang Y, Lee J-S.
Existing Evidence from Economic Evaluations of Antimicrobial Resistance—A Systematic Literature Review. Antibiotics. 2025; 14(11):1072.
https://doi.org/10.3390/antibiotics14111072
Chicago/Turabian Style
Gunarathna, Sajan, Yongha Hwang, and Jung-Seok Lee.
2025. "Existing Evidence from Economic Evaluations of Antimicrobial Resistance—A Systematic Literature Review" Antibiotics 14, no. 11: 1072.
https://doi.org/10.3390/antibiotics14111072
APA Style
Gunarathna, S., Hwang, Y., & Lee, J.-S.
(2025). Existing Evidence from Economic Evaluations of Antimicrobial Resistance—A Systematic Literature Review. Antibiotics, 14(11), 1072.
https://doi.org/10.3390/antibiotics14111072
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details
here.
Article Metrics
Article Access Statistics
For more information on the journal statistics, click
here.
Multiple requests from the same IP address are counted as one view.